Adaptive immunity to Francisella tularensis and considerations for vaccine development

Lydia M. Roberts, Daniel A. Powell, Jeffrey A Frelinger

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Francisella tularensis is an intracellular bacterium that causes the disease tularemia. There are several subspecies of F. tularensis whose ability to cause disease varies in humans. The most virulent subspecies, tularensis, is a Tier One Select Agent and a potential bioweapon. Although considerable effort has made to generate efficacious tularemia vaccines, to date none have been licensed for use in the United States. Despite the lack of a tularemia vaccine, we have learned a great deal about the adaptive immune response the underlies protective immunity. Herein, we detail the animal models commonly used to study tularemia and their recapitulation of human disease, the field's current understanding of vaccine-mediated protection, and discuss the challenges associated with new vaccine development.

Original languageEnglish (US)
Article number115
JournalFrontiers in cellular and infection microbiology
Volume8
Issue numberAPR
DOIs
StatePublished - Apr 6 2018

Fingerprint

Francisella tularensis
Tularemia
Adaptive Immunity
Vaccines
Immunity
Animal Models
Bacteria

Keywords

  • Antibodies
  • Francisella tularensis
  • Immune response
  • T cells
  • Vaccine development

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Adaptive immunity to Francisella tularensis and considerations for vaccine development. / Roberts, Lydia M.; Powell, Daniel A.; Frelinger, Jeffrey A.

In: Frontiers in cellular and infection microbiology, Vol. 8, No. APR, 115, 06.04.2018.

Research output: Contribution to journalReview article

@article{e62757c1124340858a91d3fb3a759683,
title = "Adaptive immunity to Francisella tularensis and considerations for vaccine development",
abstract = "Francisella tularensis is an intracellular bacterium that causes the disease tularemia. There are several subspecies of F. tularensis whose ability to cause disease varies in humans. The most virulent subspecies, tularensis, is a Tier One Select Agent and a potential bioweapon. Although considerable effort has made to generate efficacious tularemia vaccines, to date none have been licensed for use in the United States. Despite the lack of a tularemia vaccine, we have learned a great deal about the adaptive immune response the underlies protective immunity. Herein, we detail the animal models commonly used to study tularemia and their recapitulation of human disease, the field's current understanding of vaccine-mediated protection, and discuss the challenges associated with new vaccine development.",
keywords = "Antibodies, Francisella tularensis, Immune response, T cells, Vaccine development",
author = "Roberts, {Lydia M.} and Powell, {Daniel A.} and Frelinger, {Jeffrey A}",
year = "2018",
month = "4",
day = "6",
doi = "10.3389/fcimb.2018.00115",
language = "English (US)",
volume = "8",
journal = "Frontiers in cellular and infection microbiology",
issn = "2235-2988",
publisher = "Frontiers Media S. A.",
number = "APR",

}

TY - JOUR

T1 - Adaptive immunity to Francisella tularensis and considerations for vaccine development

AU - Roberts, Lydia M.

AU - Powell, Daniel A.

AU - Frelinger, Jeffrey A

PY - 2018/4/6

Y1 - 2018/4/6

N2 - Francisella tularensis is an intracellular bacterium that causes the disease tularemia. There are several subspecies of F. tularensis whose ability to cause disease varies in humans. The most virulent subspecies, tularensis, is a Tier One Select Agent and a potential bioweapon. Although considerable effort has made to generate efficacious tularemia vaccines, to date none have been licensed for use in the United States. Despite the lack of a tularemia vaccine, we have learned a great deal about the adaptive immune response the underlies protective immunity. Herein, we detail the animal models commonly used to study tularemia and their recapitulation of human disease, the field's current understanding of vaccine-mediated protection, and discuss the challenges associated with new vaccine development.

AB - Francisella tularensis is an intracellular bacterium that causes the disease tularemia. There are several subspecies of F. tularensis whose ability to cause disease varies in humans. The most virulent subspecies, tularensis, is a Tier One Select Agent and a potential bioweapon. Although considerable effort has made to generate efficacious tularemia vaccines, to date none have been licensed for use in the United States. Despite the lack of a tularemia vaccine, we have learned a great deal about the adaptive immune response the underlies protective immunity. Herein, we detail the animal models commonly used to study tularemia and their recapitulation of human disease, the field's current understanding of vaccine-mediated protection, and discuss the challenges associated with new vaccine development.

KW - Antibodies

KW - Francisella tularensis

KW - Immune response

KW - T cells

KW - Vaccine development

UR - http://www.scopus.com/inward/record.url?scp=85044999808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044999808&partnerID=8YFLogxK

U2 - 10.3389/fcimb.2018.00115

DO - 10.3389/fcimb.2018.00115

M3 - Review article

C2 - 29682484

AN - SCOPUS:85044999808

VL - 8

JO - Frontiers in cellular and infection microbiology

JF - Frontiers in cellular and infection microbiology

SN - 2235-2988

IS - APR

M1 - 115

ER -